As of late, it has definitely been a great time to be an investor in
Clearside Biomedical, Inc.
CLSD
. The stock has moved higher by 91.4% in the past month, while it is also above its 20 day SMA too. This combination of strong price performance and favorable technical could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider CLSD’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as CLSD has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see
the complete list of today’s Zacks #1 Rank stocks here
.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report